<DOC>
	<DOCNO>NCT01029535</DOCNO>
	<brief_summary>This prospective , open-label experience study conduct 6 clinical site Australia , objective collect efficacy safety information Juvederm® VOLUMA™ use volumising mid-face cheek area .</brief_summary>
	<brief_title>Safety Efficacy Juvederm® VOLUMA™ Correction Mid-face Volume Deficiency</brief_title>
	<detailed_description />
	<mesh_term>Hyaluronic Acid</mesh_term>
	<criteria>Subjects mild severe midface cheek volume deficit due agerelated change , likely improve least 2 grade follow treatment study compound , base studyspecific scale , assess study physician Subjects preexist medical condition receive treatment procedure may impact assessment effect study compound . Subjects history allergy side effect dermal filler , lidocaine , hyaluronic acid component study compound . Subjects pregnant breastfeed childbearing potential prepared practice adequate form contraception course study Subjects history alcoholism drug abuse dependence</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>February 2016</verification_date>
</DOC>